Abstract
Ramadurgum et al. identify 17 new stabilizers of the E. coli dihydrofolate reductase (ecDHFR) destabilizing domain (DD) and validate them both in vitro and in vivo (mouse ocular and hepatic tissue). They also demonstrate the ability of these compounds to simultaneously control endogenous (stabilizer-defined) and user-defined (ecDHFR-DD-based) pathways.
Original language | English (US) |
---|---|
Pages (from-to) | 622-634.e6 |
Journal | Cell Chemical Biology |
Volume | 27 |
Issue number | 5 |
DOIs | |
State | Published - May 21 2020 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020 Elsevier Ltd
Keywords
- E. coli dihydrofolate reductase
- chemical biology
- conditional regulation
- destabilizing domain
- dual use
- gene therapy
- high-throughput screening
- ocular
- pharmacological chaperone